170 related articles for article (PubMed ID: 22614009)
41. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines.
Pastural E; Takahashi N; Dong WF; Bainbridge M; Hull A; Pearson D; Huang S; Lowsky R; DeCoteau JF; Geyer CR
Oncogene; 2007 Mar; 26(11):1586-94. PubMed ID: 16953217
[TBL] [Abstract][Full Text] [Related]
42. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
Geli J; Nord B; Frisk T; Edström Elder E; Ekström TJ; Carling T; Bäckdahl M; Larsson C
Int J Oncol; 2005 May; 26(5):1385-91. PubMed ID: 15809732
[TBL] [Abstract][Full Text] [Related]
43. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient.
Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
Clin Cancer Res; 2003 Mar; 9(3):1033-8. PubMed ID: 12631603
[TBL] [Abstract][Full Text] [Related]
44. Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia.
Sasaki O; Meguro K; Tohmiya Y; Funato T; Shibahara S; Sasaki T
Tohoku J Exp Med; 2002 Mar; 196(3):193-201. PubMed ID: 12002276
[TBL] [Abstract][Full Text] [Related]
45. Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells.
Cheng HY; Zhang T; Qu Y; Shi WJ; Lou G; Liu YX; Zhang YY; Cheng L
Cancer Gene Ther; 2016 Nov; 23(11):392-395. PubMed ID: 27713401
[TBL] [Abstract][Full Text] [Related]
46. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
47. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
Abdollahi A; Bao R; Hamilton TC
Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
[TBL] [Abstract][Full Text] [Related]
48. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
Poetsch M; Dittberner T; Woenckhaus C
Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
[TBL] [Abstract][Full Text] [Related]
49. A histone methyltransferase is required for maximal response to female sex hormones.
Carling T; Kim KC; Yang XH; Gu J; Zhang XK; Huang S
Mol Cell Biol; 2004 Aug; 24(16):7032-42. PubMed ID: 15282304
[TBL] [Abstract][Full Text] [Related]
50. Suppression of RIZ in biologically unfavourable neuroblastomas.
Geli J; Kiss N; Kogner P; Larsson C
Int J Oncol; 2010 Nov; 37(5):1323-30. PubMed ID: 20878080
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence.
Fan SY; Jiang JD; Qian J; Lu YC; Hu GH; Luo C; Hou WD; Wang Q
PLoS One; 2015; 10(5):e0125661. PubMed ID: 25993541
[TBL] [Abstract][Full Text] [Related]
52. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
Chen LB; Xu JY; Yang Z; Wang GB
World J Gastroenterol; 2007 Nov; 13(43):5718-24. PubMed ID: 17963297
[TBL] [Abstract][Full Text] [Related]
53. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
54. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
55. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
56. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis.
Chadwick RB; Jiang GL; Bennington GA; Yuan B; Johnson CK; Stevens MW; Niemann TH; Peltomaki P; Huang S; de la Chapelle A
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2662-7. PubMed ID: 10688904
[TBL] [Abstract][Full Text] [Related]
57. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
58. RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.
Lakshmikuttyamma A; Takahashi N; Pastural E; Torlakovic E; Amin HM; Garcia-Manero G; Voralia M; Czader M; DeCoteau JF; Geyer CR
J Hematol Oncol; 2009 Jul; 2():28. PubMed ID: 19602237
[TBL] [Abstract][Full Text] [Related]
59. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
Carling T; Du Y; Fang W; Correa P; Huang S
Surgery; 2003 Dec; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
[TBL] [Abstract][Full Text] [Related]
60. RIZ1 and histone methylation status in pituitary adenomas.
Xue Y; Chen R; Du W; Yang F; Wei X
Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
